Tuesday, January 31, 2023
Clinical Advances in
Read Overview
Supported by independent educational grants from
Boehringer-Ingelheim Global
Lilly
Rapid Fire
The Link Between T2D and Kidney Disease
New Challenge
New Challenge
New Challenge
Steering Committee Chair
Head of Complications Research
Steno Diabetes Center Copenhagen
Herlev, Denmark
Professor, Department of Clinical Medicine
University of Copenhagen
Copenhagen, Denmark
Steering Committee Member
Professor of Medicine
University of Toronto
Clinician Scientist
Division of Nephrology
University Health Network
Senior Scientist
Toronto General Hospital Research Institute
Director
Renal Physiology Laboratory
University Health Network
Toronto, Ontario, Canada
Steering Committee Member
Primary Care Physician
Northenden Group Practice
Manchester, United Kingdom
Steering Committee Member
Clinical Professor of Medicine
University of California
Irvine Medical Center
Irvine, California, United States
Steering Committee Member
Professor of Medicine
David Geffen School of Medicine
University of California
Los Angeles, California, United States
Steering Committee Member
Professor of Medicine
University of Manitoba
Winnipeg, Manitoba, Canada
Steering Committee Chair
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Astellas; Abbott; Bayer; Boehringer Ingelheim; Eli Lilly; Gilead Sciences; Novo Nordisk; Sanofi
Speaker or member of speakers bureau for: AstraZeneca; Astellas; Bayer; Boehringer Ingelheim; Merck; Novo Nordisk
Research funding from: AstraZeneca; Bayer; Novo Nordisk
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AbbVie; AstraZeneca; Bayer; Boehringer Ingelheim-Lilly; Bristol Myers Squibb; CSL-Behring; Gilead Sciences; Janssen; Lexicon; Maze; Merck; Mitsubishi-Tanabe; Novartis; Novo Nordisk; Prometic; Otsuka; Sanofi; Youngene
Research funding from: AstraZeneca; Boehringer Ingelheim-Lilly; CSL-Behring; Janssen; Merck; Novo Nordisk; Sanofi
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Boehringer Ingelheim; Liva Health; Novo Nordisk
Speaker or member of speakers bureau for: AstraZeneca; Boehringer Ingelheim
Employed by an ineligible company: Medical director for Liva Health
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes Care; AstraZeneca; Bayer; Boehringer Ingelheim-Lilly; GlaxoSmithKline; Immuvent (former); INTUITY (former); Janssen; Novo Nordisk (former); Phathom (former); RevHealth (former)
Speaker or member of speakers bureau for: AstraZeneca; Bayer; Boehringer Ingelheim-Lilly; GlaxoSmithKline; Janssen; Novo Nordisk (former)
Owns stock (publicly traded) in: Abbott
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Bayer; Boehringer Ingelheim-Lilly; Janssen
Speaker or member of speakers bureau for: AstraZeneca; Boehringer Ingelheim-Lilly
Research funding from: Bayer; Goldfinch; Travere
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Bayer; Boehringer Ingelheim-Lilly; Janssen; Otsuka; Tricida
Research funding from: AstraZeneca; Bayer; Boehringer Ingelheim-Lilly; Janssen; Otsuka; Tricida
Stock options from: Mesentech; Renibus; Tricida
Ownership interest: Clinpredict; Klinrisk